GlaxoSmithKline - Corporate Executive team

JP Garnier
CHIEF EXECUTIVE OFFICER

JP was the Chief Executive Officer of SmithKline Beecham. He joined SmithKline Beecham in 1990 as President of its pharmaceutical business in North America and served as Chairman, Pharmaceuticals, from 1994 until his appointment as Chief Operating Officer in 1995. JP was elected to SmithKline Beecham’s Board of Directors in 1992.

Jim Beery
SENIOR VICE PRESIDENT & GENERAL COUNSEL

Jim was the Senior Vice President, General Counsel and Corporate Secretary, for SmithKline Beecham, having joined the company in 1994. Jim is responsible for legal matters across the group.

Jim will retire from GlaxoSmithKline in June 2001.

John Coombe
CHIEF FINANCIAL OFFICER

John was the Group Finance Director of Glaxo Wellcome plc. He joined Glaxo in 1986 as Group Financial Controller and was appointed to the Board in 1992 as the Executive Director responsible for finance. He subsequently added responsibility for Investor Relations.

Bob Ingram
CHIEF OPERATING OFFICER & PRESIDENT PHARMACEUTICAL OPERATIONS

Bob was Chief Executive of Glaxo Wellcome plc and Chairman of its US subsidiary, Glaxo Wellcome Inc. He joined Glaxo Inc in 1990 from Merck, and was appointed to the Board of Glaxo Wellcome in 1995. In 1997 he became Chief Executive of Glaxo Wellcome, responsible for global business operations.

Jim Niedel
CHIEF SCIENCE & TECHNOLOGY OFFICER

Jim was the Glaxo Wellcome Executive Director responsible for Science & Technology. He was appointed to the Glaxo Wellcome Board in 1995 with responsibility for Group Research and Development and Information Technology. Before he joined Glaxo Wellcome in 1988, Jim was Professor of Medicine and Chief of the Division of Clinical Pharmacology at Duke University Medical Center.

James Palmer
SENIOR VICE PRESIDENT NEW PRODUCT DEVELOPMENT PHARMACEUTICALS R&D

James was responsible for all Glaxo Wellcome’s medical, regulatory and product strategy activities worldwide and in this role was a member of the Glaxo Wellcome Executive Committee. A physician by training, James joined Glaxo in 1985.

Dan Phelan
SENIOR VICE PRESIDENT HUMAN RESOURCES

Appointed Senior Vice President and Director, Human Resources, SmithKline Beecham, in 1994. Before that he was Senior Vice President and Director, Operations and Administration, Research and Development. In 1989, he was appointed Vice President and Director, Personnel – US, Pharmaceuticals. He joined SmithKline Beecham as Manager of Labour Relations in 1981.

Howard Pien
PRESIDENT PHARMACEUTICALS INTERNATIONAL

With responsibility for the commercial operations of the worldwide Pharmaceuticals business, Howard became President, Pharmaceuticals, SmithKline Beecham, in 1998. He has held key positions in the USA, the UK and North Asia. He joined SmithKline Beecham in 1991 having worked at Abbott Laboratories and Merck.

David Stout
PRESIDENT US PHARMACEUTICAL

Appointed President, Pharmaceuticals, North America, SmithKline Beecham, in 1998. He joined SmithKline Beecham in 1996 as Senior Vice President and Director, Sales and Marketing – US. Before that he was President of Schering Laboratories with responsibilities including US pharmaceutical operations and worldwide manufacturing.

Tim Tyson
PRESIDENT GLOBAL MANUFACTURING & SUPPLY

Tim was appointed Senior Vice President and Director, Worldwide Manufacturing & Supply, Glaxo Wellcome, in 1998. He was previously Vice President and General Manager of Business Operations and Marketing for Glaxo Wellcome Inc. He joined the company in 1988. He was a member of the Glaxo Wellcome Executive Committee.

Chris Viehbacher
PRESIDENT PHARMACEUTICALS EUROPE

As Regional Director for Europe, Chris was a member of the Glaxo Wellcome Executive Committee. He became Director, Continental Europe, in January 1999 in addition to his role as Chairman and Chief Executive (President Directeur General) of Glaxo Wellcome France. He joined Glaxo Wellcome in 1988.

Tachi Yamada
CHAIRMAN RESEARCH & DEVELOPMENT

Tachi was appointed Chairman, Research and Development, Pharmaceuticals, in 1999. Previously he was President, SmithKline Beecham Healthcare Services. He was a member of SmithKline Beecham’s Board. He was formerly Chairman of the Department of Internal Medicine at the University of Michigan Medical School and Physician-in-Chief of the University of Michigan Medical Center.

Jack Ziegler
PRESIDENT CONSUMER HEALTHCARE

Appointed as President of Consumer Healthcare, SmithKline Beecham, in 1998, Jack was responsible for the company's global Consumer Healthcare operations. He joined SmithKline Beecham in 1991 as head of the North American Consumer Healthcare division, became President of the North America Division and in 1996 was appointed Executive Vice President.